You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Important cost categories not included: transcatheter aortic valve implantation probably less cost-effective
  1. Pieter van Baal
  1. Correspondence to Dr Pieter van Baal, Institute of Health Policy & Management, Erasmus University Rotterdam, PO Box 1, Rotterdam 3720BA, The Netherlands; vanbaal{at}bmg.eur.nl

https://doi.org/10.1136/heartjnl-2012-302272

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Patients eligible for the transcatheter aortic valve implantation (TAVI) intervention are old (>75 years), face a high risk of mortality, and generally have multiple comorbidities.1 Healthcare consumption of this group of patients can, therefore, be expected to be high.2 ,3 As a consequence, life extension in this group would probably result …

    View Full Text

    Footnotes

    • Linked articles 302273.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles

    • PostScript
      The Authors' reply
      Maureen Watt Stuart Mealing Mealing Eaton Mark Sculpher Pascale Brasseur Rachele Busca Nicolo Piazza Stephen Palmer Neil Moat
      Heart 2012; 98 1182-1182 Published Online First: 15 Jun 2012. doi: 10.1136/heartjnl-2012-302273